Dashboard
Manage Tickers

RXSTRxSight, Inc.

Nasdaq rxsight.com


$ 54.99 $ -0.32 (-0.58 %)    

Monday, 16-Sep-2024 09:49:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.72 $ -0.34 (-0.07 %)
DIA $ 417.82 $ 0.86 (0.21 %)
SPY $ 561.89 $ 0.42 (0.07 %)
TLT $ 100.55 $ -0.08 (-0.08 %)
GLD $ 238.90 $ 0.29 (0.12 %)
$ 54.96
$ 55.31
$ 54.91 x 200
$ 75.00 x 100
$ 54.77 - $ 55.31
$ 20.66 - $ 66.54
378,222
na
2.18B
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-06-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 09-09-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peeling-back-the-layers-exploring-rxsight-through-analyst-insights
Peeling Back The Layers: Exploring RxSight...
09/13/2024 12:00:40

needham-reiterates-buy-on-rxsight-maintains-66-price-target
Needham Reiterates Buy on RxSight, Maintai...
09/13/2024 10:40:27

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $66 price target.

needham-maintains-buy-on-rxsight-raises-price-target-to-66
Needham Maintains Buy on RxSight, Raises P...
08/20/2024 16:25:11

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $54 to $66.

deep-dive-into-rxsight-stock-analyst-perspectives-6-ratings
Deep Dive Into RxSight Stock: Analyst Pers...
08/06/2024 20:01:18

wells-fargo-maintains-overweight-on-rxsight-lowers-price-target-to-54
Wells Fargo Maintains Overweight on RxSigh...
08/06/2024 15:10:41

Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Overweight and lowers the price target from $68 t...

lithia-motors-to-rally-around-14-here-are-10-top-analyst-forecasts-for-tuesday
Lithia Motors To Rally Around 14%? Here Ar...
08/06/2024 14:06:32

rxsight-analysts-slash-their-forecasts-after-q2-results
RxSight Analysts Slash Their Forecasts Aft...
08/06/2024 12:12:37

oppenheimer-maintains-outperform-on-rxsight-lowers-price-target-to-65
Oppenheimer Maintains Outperform on RxSigh...
08/06/2024 11:59:25

Oppenheimer analyst Steven Lichtman maintains RxSight (NASDAQ:RXST) with a Outperform and lowers the price target from $72 t...

stifel-maintains-buy-on-rxsight-lowers-price-target-to-65
Stifel Maintains Buy on RxSight, Lowers Pr...
08/06/2024 11:31:06

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $70 to $65.

needham-maintains-buy-on-rxsight-lowers-price-target-to-54
Needham Maintains Buy on RxSight, Lowers P...
08/06/2024 10:10:23

Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $75 to $54.

why-palantir-technologies-shares-are-trading-higher-by-around-10-here-are-20-stocks-moving-premarket
Why Palantir Technologies Shares Are Tradi...
08/06/2024 09:16:05

rxsight-raises-fy24-revenue-forecast-from-132m---137m-to-139m---140m-est-135071m
RxSight Raises FY24 Revenue Forecast From ...
08/05/2024 21:03:51

Operating expenses in the range of $135.0 million to $136.0 million, representing an implied increase of 30% to 31% compared ...

rxsight-q2-sales-34887m-beat-32283m-estimate
RxSight Q2 Sales $34.887M Beat $32.283M Es...
08/05/2024 20:26:11

RxSight (NASDAQ:RXST) reported quarterly sales of $34.887 million which beat the analyst consensus estimate of $32.283 million ...

johnson--johnson-q2-earnings-preview-can-new-drugs-lift-sagging-stock
Johnson & Johnson Q2 Earnings Preview: Can...
07/16/2024 19:07:10

Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?

rxsight-stock-a-deep-dive-into-analyst-perspectives-7-ratings
RxSight Stock: A Deep Dive Into Analyst Pe...
07/15/2024 20:01:27

btig-maintains-buy-on-rxsight-raises-price-target-to-73
BTIG Maintains Buy on RxSight, Raises Pric...
07/15/2024 16:56:36

BTIG analyst Ryan Zimmerman maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $72 to $73.

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

stifel-maintains-buy-on-rxsight-lowers-price-target-to-70
Stifel Maintains Buy on RxSight, Lowers Pr...
07/10/2024 13:25:27

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $75 to $70.

why-rxsight-rxst-shares-are-falling
Why RxSight (RXST) Shares Are Falling
05/09/2024 16:01:13

RxSight shares are trading lower by 5.6% during Thursday's session. The company announced pricing of its $100 million propo...

reported-earlier-rxsight-prices-public-offering-of-1785714-common-stock-at-56share
Reported Earlier, RxSight Prices Public Of...
05/09/2024 08:29:19

RxSight expects to sell 1,785,714 shares of its common stock at a price to the public of $56.00 per share. RxSight has granted ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION